Stock Research for AOLS


Featured Broker: Ally Invest

Get the due diligence for another stock.


AOLS Stock Chart & Research Data

The AOLS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AOLS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


AOLS Due diligence Resources & Stock Charts

The AOLS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AOLS Detailed Price Forecast - CNN Money CNN View AOLS Detailed Summary - Google Finance
Yahoo View AOLS Detailed Summary - Yahoo! Finance Zacks View AOLS Stock Research & Analysis -

Stock Analysis

TradeIdeas View AOLS Trends & Analysis - Trade-Ideas Barrons View AOLS Major Holders - Barrons
NASDAQ View AOLS Call Transcripts - NASDAQ Seeking View AOLS Breaking News & Analysis - Seeking Alpha
Spotlight View AOLS Annual Report - OTC Report View AOLS OTC Short Report -
TradeKing View AOLS Fundamentals - TradeKing Charts View AOLS SEC Filings - Bar Chart
WSJ View Historical Prices for AOLS - The WSJ Morningstar View Performance/Total Return for AOLS - Morningstar
MarketWatch View the Analyst Estimates for AOLS - MarketWatch CNBC View the Earnings History for AOLS - CNBC
StockMarketWatch View the AOLS Earnings - StockMarketWatch MacroAxis View AOLS Buy or Sell Recommendations - MacroAxis
Bullish View the AOLS Bullish Patterns - American Bulls Short Pains View AOLS Short Pain Metrics -

Social Media Mentions

StockTwits View AOLS Stock Mentions - StockTwits PennyStocks View AOLS Stock Mentions - PennyStockTweets
Twitter View AOLS Stock Mentions - Twitter Invest Hub View AOLS Investment Forum News - Investor Hub
Yahoo View AOLS Stock Mentions - Yahoo! Message Board Seeking Alpha View AOLS Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for AOLS - Insider Cow View Insider Transactions for AOLS - Insider Cow
CNBC View AOLS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AOLS - OTC Markets
Yahoo View Insider Transactions for AOLS - Yahoo! Finance NASDAQ View Institutional Holdings for AOLS - NASDAQ

Stock Charts

FinViz View AOLS Stock Insight & Charts - StockCharts View AOLS Investment Charts -
BarChart View AOLS Stock Overview & Charts - BarChart Trading View View AOLS User Generated Charts - Trading View

Latest Financial News for AOLS

Aeolus Announces Commencement of Assignment for the Benefit of Creditors
Posted on Friday March 23, 2018

MISSION VIEJO, CA / ACCESSWIRE / March 23, 2018 / Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), announced today that it has commenced an out-of-court liquidation conducted by an Assignment for the Benefit ...

Aeolus Announces Presentation of Pharmacometric Analysis Confirming Statistically Significant Improvement in Survival 6 Months After Exposure to Lethal Thoracic Radiation Following Treatment with AEOL 10150
Posted on Tuesday September 26, 2017

- AEOL 10150 Treatment Once Per Day for 60 Days Beginning 24 Hours Post-Exposure Reduced Mortality by 50 Percent - AEOL 10150 Is The Only Drug in Advanced Development by The US Government to Address the ...

Aeolus Announces Presentation of Pharmacometric Analysis of Data Establishing Optimal Dose Schedule of AEOL 10150 for Treatment of Lung Radiation Damage
Posted on Friday September 22, 2017

AEOL 10150 treatment once per day for 60 days beginning 24 hours post-exposure: - significantly improved survival at 180 Days - delayed onset of lethal effects by 90 days - Increased mean survival at 360 ...

Aeolus Announces Publication of Data Demonstrating that Adding AEOL 10150 to Standard Therapy After Nerve Agent Exposure Improves Survival and Reduces Brain Damage and Nerve Inflammation in Rats
Posted on Wednesday September 20, 2017

Exposure to the Nerve Agent Surrogate Pilocarpine Causes Prolonged Seizures (Status Epilepticus) that Result in Significant Oxidative Stress Status Epilepticus Induced Oxidative Stress Causes Brain Damage, ...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.